- Recommendation ID
- Effectiveness of biomarkers for determining level of risk of colorectal cancer:- Which biomarkers, including epigenic and genetic markers, are predictors of colorectal cancer? How should these be used to improve risk stratification?
- Any explanatory notes
- Why this is important:- There is no high quality evidence on the predictive value of biomarkers, including epigenic and genetic markers, for colorectal cancer in people with inflammatory bowel disease (IBD) or adenomas. Research should be undertaken to identify the biomarkers that are predictive of colorectal cancer, if any can improve levels of early detection, and how they can be used to improve risk stratification.
Source guidance details
- Comes from guidance
- Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas
- Date issued
- March 2011
|Is this a recommendation for the use of a technology only in the context of research?||No|
|Is it a recommendation that suggests collection of data or the establishment of a register?||No|